| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/06/2001 | DE10006887A1 Modulators of regulatory protein RS1, useful for treating diabetes or tumors and for increasing drug transport, control concentration of transport proteins in plasma membranes |
| 09/05/2001 | EP1130123A2 Diagnostic method |
| 09/05/2001 | EP1130106A1 Non-squamous epithelium-specific transcription |
| 09/05/2001 | EP1130099A1 Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| 09/05/2001 | EP1130096A1 Proliferation arrest trancription factor (PATF) and its use |
| 09/05/2001 | EP1130088A1 Hybrid cell vaccines |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1130031A1 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity |
| 09/05/2001 | EP1129724A2 Vaccines for treating colon cancer |
| 09/05/2001 | EP1129718A2 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/05/2001 | EP1129717A1 Use of homologues of staphylococcal enterotoxins for cancer treatment |
| 09/05/2001 | EP1129715A1 Use of magnesium, calcium and silicon for the healing of different diseases and to the general well-being |
| 09/05/2001 | EP1129350A1 Methods for identifying modulators of bs69 activity |
| 09/05/2001 | EP1129199A2 Cell signaling polypeptides and nucleic acids |
| 09/05/2001 | EP1129190A1 Human tslp dna and polypeptides |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1129188A1 Pge synthase and methods and means for modulating its activity |
| 09/05/2001 | EP1129181A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 09/05/2001 | EP1129110A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 09/05/2001 | EP1129086A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 09/05/2001 | EP1129084A2 Ppar gamma ligands |
| 09/05/2001 | EP1129076A1 Tetrahydroisoquinoline derivatives as lhrh antagonists |
| 09/05/2001 | EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 09/05/2001 | EP1129074A2 Antrhranilic acid amides and the use thereof as medicaments |
| 09/05/2001 | EP1129070A1 Neurotrophic diamide and carbamate agents |
| 09/05/2001 | EP1129068A1 Bicyclic signal transduction inhibitors, composition containing them and uses thereof |
| 09/05/2001 | EP1128848A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 09/05/2001 | EP1128823A1 Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis |
| 09/05/2001 | EP1128814A1 Aerosols comprising nanoparticle drugs |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | EP1128812A1 Nano-emulsion of 5-aminolevulinic acid |
| 09/05/2001 | EP1128731A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 09/05/2001 | EP1128727A1 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| 09/05/2001 | EP1070057A4 7-hexanoyltaxol and methods for preparing the same |
| 09/05/2001 | EP1000075A4 Method of producing tiazofurin and other c-nucleosides |
| 09/05/2001 | EP0873304B1 Metalloproteinase inhibitors |
| 09/05/2001 | EP0799038B1 NEW USES OF INDOLO-[2,3b]-QUINOXALINES |
| 09/05/2001 | EP0738114B1 Food products for preventing development of diseases and process for preparing same |
| 09/05/2001 | EP0637300B1 Antiproliferative quinazolines |
| 09/05/2001 | CN1311796A Peptide antiangiogenic drugs |
| 09/05/2001 | CN1311775A Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/05/2001 | CN1311692A Farnesyl protein transferase inhibitors with i(IN VIVO) Radiosensitizing |
| 09/05/2001 | CN1311682A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol |
| 09/05/2001 | CN1311678A Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 09/05/2001 | CN1311676A Compound that inhibit the binding of integrins to their receptors |
| 09/05/2001 | CN1311674A Antioxidant, antiproliferous compositions, comprising a carnitine and a cerotenoid |
| 09/05/2001 | CN1311671A Peptidyl-prolyl i-(cis)-trans isomerase inhitors and uses thereof |
| 09/05/2001 | CN1311629A Inhibitors of transcription factor NF-KB |
| 09/05/2001 | CN1311329A New polypeptide-human phosphomannose isomerase 16 and polynucleotide for coding such polypeptide |
| 09/05/2001 | CN1311245A New polypeptide-human zinc finger protein 72 and polynucleotide for coding such polypeptide |
| 09/05/2001 | CN1311216A New polypeptide-human microtubulin 11 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311204A New polypeptide-human adenosine triphosphate 30 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311202A New polypeptide-human reverse transcription relative factor 22 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311186A Deuteroporphyvin derivative, its preparing method and freeze dried preparation for injection |
| 09/05/2001 | CN1311183A Anti-tumor bis-dicarboxylic diamino platinum derivatives and its medicinal composition |
| 09/05/2001 | CN1311035A Recombination high efficiency composite interferon used as hepatitis B surface antigen and e antigen inhibitor |
| 09/05/2001 | CN1311034A Use of LT limulus peptide in preparing anti-cancer medicine |
| 09/05/2001 | CN1311033A Chinese medicine for curing cancer |
| 09/05/2001 | CN1311018A Chinese herbal plaster for anti-cancer and analgesic |
| 09/05/2001 | CN1311015A Natural medicine for anti-virus, anti-heavy metals and anti-tumor |
| 09/05/2001 | CN1311012A Preparing method for auxiliary feedback treatment of disease medicine |
| 09/05/2001 | CN1311005A Traditional Chinese herb medicine prepn. for treating cancer |
| 09/05/2001 | CN1070372C Powerful anti-cancer plaster and its prepn. method |
| 09/04/2001 | US6285537 Stress-follower circuit configuration |
| 09/04/2001 | US6284882 Myostatin gene promoter and inhibition of activation thereof |
| 09/04/2001 | US6284786 Treatment of cancer using lipoic acid in combination with ascorbic acid |
| 09/04/2001 | US6284784 2-hydroxymethyl derivatives |
| 09/04/2001 | US6284768 Src family SH2 domain inhibitors |
| 09/04/2001 | US6284764 Antiproliferative agent |
| 09/04/2001 | US6284757 Antiserotinone agent |
| 09/04/2001 | US6284751 Carpal tunnel syndrome; adult respiatory suystem disorders; antitumor agents |
| 09/04/2001 | US6284742 Administering adenovirus and antibodies |
| 09/04/2001 | US6284741 Genetic engineered nucleic acid |
| 09/04/2001 | US6284737 Methods of treatment with anthracycline derivatives |
| 09/04/2001 | US6284540 Neuronal trophic support and cell differentiation by introducing nucleotide sequence |
| 09/04/2001 | US6284491 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 09/04/2001 | US6284464 Inhibition of binding of Hox and homeodomain-containing proteins and uses thereof |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | US6284249 Fusion polypeptide having the C protein and E1 protein of hepatitis C virus |
| 09/04/2001 | CA2205430C Method for making a medicament for treating secondary immunodeficiency |
| 08/30/2001 | WO2001063244A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | WO2001062973A1 Antisense modulation of e2f transcription factor 3 expression |
| 08/30/2001 | WO2001062942A2 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 08/30/2001 | WO2001062932A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 08/30/2001 | WO2001062931A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 08/30/2001 | WO2001062930A1 Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062920A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 08/30/2001 | WO2001062916A1 Novel armadillo repeat-containing protein alex1 |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062911A2 Antisense and catalytically acting nucleic acid molecules targeted to grb2- related with insert domain (grid) proteins and their uses |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062902A1 Hybrid cell vaccines |
| 08/30/2001 | WO2001062895A2 Simultaneous stimulation and concentration of cells |
| 08/30/2001 | WO2001062800A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
| 08/30/2001 | WO2001062799A2 Method for inhibiting angiogenesis using molecules that enhance plasmin activity |
| 08/30/2001 | WO2001062795A1 COMPOUNDS RELATED TO OR DERIVED FROM GFRα4 AND THEIR USE |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062786A2 Tlp peptides and dna sequences coding the same |